Share Price and Basic Stock Data
Last Updated: February 14, 2026, 9:57 pm
| PEG Ratio | 2.80 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Axel Polymers Ltd operates in the plastics sector, focusing on plastic and plastic products. The company has reported a current price of ₹43.5 and a market capitalization of ₹47.9 Cr. Over the last fiscal year, the company’s sales rose significantly, recording ₹82.65 Cr for the year ending March 2023, up from ₹72.91 Cr in March 2022. This upward trend continued into the current fiscal year, with sales reaching ₹127.92 Cr for March 2024. The quarterly sales figures reflect a robust growth trajectory, with the latest quarter (September 2023) posting ₹30.92 Cr in sales, compared to ₹21.45 Cr in September 2022. This consistent revenue growth indicates a strong demand for the company’s products in the market. However, the trailing twelve months (TTM) revenue stood at ₹47.86 Cr, which suggests fluctuations in sales performance. The company’s ability to sustain growth amidst market competition will be critical for future revenue stability.
Profitability and Efficiency Metrics
Axel Polymers Ltd’s profitability metrics reveal a mixed performance. The operating profit margin (OPM) for the year ending March 2023 stood at 6.19%, a decline from 5.64% in March 2022. The net profit for the same period was ₹1.18 Cr, translating to an earnings per share (EPS) of ₹1.39. However, the company faces challenges, as the OPM fell sharply to 4.50% in the September 2023 quarter. The interest coverage ratio (ICR) was reported at 1.27x, indicating that the company’s earnings are just above its interest obligations, which is a sign of moderate financial strain. Additionally, the return on equity (ROE) stood at 1.13%, significantly lower than industry averages, suggesting that shareholder returns are not optimally leveraged. While there are glimpses of operational efficiency improvements, particularly in the trailing twelve months, the overall profitability metrics highlight areas needing attention to enhance margins and returns.
Balance Sheet Strength and Financial Ratios
The balance sheet of Axel Polymers Ltd exhibits a mix of strengths and weaknesses. The total borrowings amount to ₹31.82 Cr, while reserves are reported at ₹6.71 Cr, indicating a debt-to-equity ratio of approximately 2.25x, which is relatively high compared to typical sector ranges. This high leverage poses risks, particularly in economic downturns. The company’s working capital days stood at 29.87, while the cash conversion cycle (CCC) was recorded at 175.64 days, suggesting inefficiencies in managing receivables and inventory. However, the book value per share increased to ₹17.77 as of March 2025, reflecting a gradual strengthening of the company’s equity base. Financial ratios such as the current ratio at 1.19x indicate a stable liquidity position, which is crucial for meeting short-term obligations. These factors suggest that while the company has a reasonable asset base, its reliance on debt may hinder future growth prospects.
Shareholding Pattern and Investor Confidence
Promoter holding in Axel Polymers Ltd stands at 61.16%, showcasing substantial insider control, which can be a sign of stability and confidence in the company’s direction. The presence of domestic institutional investors (DIIs) is minimal at 0.24%, while public shareholders account for 38.61%, with the total number of shareholders reported at 10,067. This distribution indicates a predominantly retail investor base, which could lead to volatility in stock performance based on market sentiment. The gradual decline in promoter holding from 61.90% in December 2022 to 61.16% in March 2025 may raise concerns among investors regarding potential dilution of control. Despite this, the consistent shareholding pattern suggests a level of confidence from promoters. However, the lack of foreign institutional investment (FIIs) could be a concern, as it limits the potential for broader market validation and support.
Outlook, Risks, and Final Insight
Looking ahead, Axel Polymers Ltd faces both opportunities and challenges. The company’s strong revenue growth trajectory is promising, but the declining profitability margins and high debt levels pose significant risks. As the company navigates market fluctuations, it must focus on improving operational efficiencies to enhance profitability. Additionally, strengthening its balance sheet by managing debt levels and optimizing working capital will be crucial for sustainable growth. The current market dynamics suggest potential for further expansion, given the rising demand for plastic products. However, the company’s high reliance on debt could become a liability if not managed prudently. Stakeholders will need to monitor these metrics closely, especially as Axel Polymers seeks to leverage its market position while addressing the inherent risks associated with its financial structure. Maintaining investor confidence will also be essential for long-term stability.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mitsu Chem Plast Ltd | 156 Cr. | 115 | 128/83.2 | 13.6 | 73.6 | 0.17 % | 10.4 % | 8.17 % | 10.0 |
| IIRM Holdings India Ltd | 644 Cr. | 94.5 | 108/68.0 | 32.2 | 21.3 | 0.00 % | 23.5 % | 18.6 % | 5.00 |
| Fiberweb (India) Ltd | 132 Cr. | 46.0 | 59.4/31.2 | 8.00 | 63.9 | 0.00 % | 10.0 % | 8.88 % | 10.0 |
| Deep Polymers Ltd | 85.6 Cr. | 35.4 | 67.4/34.1 | 19.4 | 37.5 | 0.00 % | 8.22 % | 6.10 % | 10.0 |
| DDev Plastiks Industries Ltd | 2,897 Cr. | 280 | 360/213 | 14.6 | 88.5 | 0.62 % | 33.9 % | 24.9 % | 1.00 |
| Industry Average | 1,563.58 Cr | 445.76 | 46.22 | 183.16 | 0.35% | 16.30% | 12.17% | 8.25 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 21.45 | 17.74 | 27.18 | 25.81 | 30.92 | 38.65 | 37.28 | 42.24 | 13.87 | 11.11 | 14.33 | 11.70 | 10.72 |
| Expenses | 20.42 | 16.58 | 25.29 | 24.28 | 29.53 | 37.18 | 35.85 | 41.93 | 13.72 | 10.95 | 11.03 | 10.70 | 9.79 |
| Operating Profit | 1.03 | 1.16 | 1.89 | 1.53 | 1.39 | 1.47 | 1.43 | 0.31 | 0.15 | 0.16 | 3.30 | 1.00 | 0.93 |
| OPM % | 4.80% | 6.54% | 6.95% | 5.93% | 4.50% | 3.80% | 3.84% | 0.73% | 1.08% | 1.44% | 23.03% | 8.55% | 8.68% |
| Other Income | 0.08 | 0.03 | 0.12 | 0.01 | 0.01 | 0.01 | 0.01 | 0.03 | 0.01 | 0.01 | 0.09 | 0.01 | 0.02 |
| Interest | 0.76 | 0.82 | 0.86 | 0.80 | 0.78 | 0.67 | 0.62 | 0.75 | 0.85 | 0.81 | 0.82 | 0.82 | 0.79 |
| Depreciation | 0.10 | 0.10 | 0.24 | 0.12 | 0.12 | 0.12 | 0.34 | 0.12 | 0.12 | 0.12 | 0.20 | 0.15 | 0.15 |
| Profit before tax | 0.25 | 0.27 | 0.91 | 0.62 | 0.50 | 0.69 | 0.48 | -0.53 | -0.81 | -0.76 | 2.37 | 0.04 | 0.01 |
| Tax % | 0.00% | 0.00% | 54.95% | 0.00% | 0.00% | 2.90% | 114.58% | 0.00% | 0.00% | 0.00% | 5.91% | 0.00% | 0.00% |
| Net Profit | 0.25 | 0.27 | 0.41 | 0.62 | 0.50 | 0.67 | -0.07 | -0.53 | -0.81 | -0.76 | 2.23 | 0.04 | 0.01 |
| EPS in Rs | 0.29 | 0.32 | 0.48 | 0.73 | 0.59 | 0.79 | -0.08 | -0.62 | -0.95 | -0.89 | 2.62 | 0.05 | 0.01 |
Last Updated: December 27, 2025, 11:05 pm
Below is a detailed analysis of the quarterly data for Axel Polymers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 10.72 Cr.. The value appears to be declining and may need further review. It has decreased from 11.70 Cr. (Jun 2025) to 10.72 Cr., marking a decrease of 0.98 Cr..
- For Expenses, as of Sep 2025, the value is 9.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 10.70 Cr. (Jun 2025) to 9.79 Cr., marking a decrease of 0.91 Cr..
- For Operating Profit, as of Sep 2025, the value is 0.93 Cr.. The value appears to be declining and may need further review. It has decreased from 1.00 Cr. (Jun 2025) to 0.93 Cr., marking a decrease of 0.07 Cr..
- For OPM %, as of Sep 2025, the value is 8.68%. The value appears strong and on an upward trend. It has increased from 8.55% (Jun 2025) to 8.68%, marking an increase of 0.13%.
- For Other Income, as of Sep 2025, the value is 0.02 Cr.. The value appears strong and on an upward trend. It has increased from 0.01 Cr. (Jun 2025) to 0.02 Cr., marking an increase of 0.01 Cr..
- For Interest, as of Sep 2025, the value is 0.79 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 0.82 Cr. (Jun 2025) to 0.79 Cr., marking a decrease of 0.03 Cr..
- For Depreciation, as of Sep 2025, the value is 0.15 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.15 Cr..
- For Profit before tax, as of Sep 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Jun 2025) to 0.01 Cr., marking a decrease of 0.03 Cr..
- For Tax %, as of Sep 2025, the value is 0.00%. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 0.00%.
- For Net Profit, as of Sep 2025, the value is 0.01 Cr.. The value appears to be declining and may need further review. It has decreased from 0.04 Cr. (Jun 2025) to 0.01 Cr., marking a decrease of 0.03 Cr..
- For EPS in Rs, as of Sep 2025, the value is 0.01. The value appears to be declining and may need further review. It has decreased from 0.05 (Jun 2025) to 0.01, marking a decrease of 0.04.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 4:08 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 5.56 | 16.19 | 18.53 | 21.94 | 26.97 | 24.37 | 22.90 | 48.32 | 72.91 | 82.65 | 127.92 | 78.09 | 47.86 |
| Expenses | 6.05 | 14.74 | 17.37 | 20.81 | 25.65 | 22.71 | 21.51 | 44.41 | 68.80 | 77.53 | 122.12 | 74.13 | 42.47 |
| Operating Profit | -0.49 | 1.45 | 1.16 | 1.13 | 1.32 | 1.66 | 1.39 | 3.91 | 4.11 | 5.12 | 5.80 | 3.96 | 5.39 |
| OPM % | -8.81% | 8.96% | 6.26% | 5.15% | 4.89% | 6.81% | 6.07% | 8.09% | 5.64% | 6.19% | 4.53% | 5.07% | 11.26% |
| Other Income | 0.03 | 0.04 | 0.08 | 0.27 | 0.04 | 0.02 | 0.02 | 0.40 | 0.55 | 0.28 | 0.04 | 0.14 | 0.13 |
| Interest | 0.87 | 0.88 | 0.84 | 0.93 | 0.79 | 0.91 | 0.97 | 3.32 | 2.84 | 3.16 | 2.85 | 3.23 | 3.24 |
| Depreciation | 0.45 | 0.48 | 0.25 | 0.21 | 0.28 | 0.33 | 0.36 | 0.42 | 0.48 | 0.54 | 0.70 | 0.56 | 0.62 |
| Profit before tax | -1.78 | 0.13 | 0.15 | 0.26 | 0.29 | 0.44 | 0.08 | 0.57 | 1.34 | 1.70 | 2.29 | 0.31 | 1.66 |
| Tax % | 0.00% | 0.00% | 0.00% | 15.38% | 17.24% | -6.82% | -12.50% | -15.79% | 31.34% | 30.59% | 31.88% | 41.94% | |
| Net Profit | -1.78 | 0.12 | 0.15 | 0.22 | 0.23 | 0.47 | 0.09 | 0.66 | 0.92 | 1.18 | 1.56 | 0.17 | 1.52 |
| EPS in Rs | -4.14 | 0.28 | 0.35 | 0.51 | 0.53 | 1.09 | 0.21 | 1.53 | 1.08 | 1.39 | 1.83 | 0.20 | 1.79 |
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | 106.74% | 25.00% | 46.67% | 4.55% | 104.35% | -80.85% | 633.33% | 39.39% | 28.26% | 32.20% | -89.10% |
| Change in YoY Net Profit Growth (%) | 0.00% | -81.74% | 21.67% | -42.12% | 99.80% | -185.20% | 714.18% | -593.94% | -11.13% | 3.94% | -121.31% |
Axel Polymers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 28% |
| 3 Years: | 2% |
| TTM: | -66% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 4% |
| 5 Years: | 14% |
| 3 Years: | -43% |
| TTM: | 23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 40% |
| 3 Years: | 8% |
| 1 Year: | -17% |
| Return on Equity | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 7% |
| 3 Years: | 7% |
| Last Year: | 1% |
Last Updated: September 5, 2025, 2:31 pm
Balance Sheet
Last Updated: February 1, 2026, 2:24 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 4.30 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 | 8.52 |
| Reserves | -3.31 | -3.44 | -3.29 | -3.09 | -2.84 | -2.37 | -2.31 | 2.90 | 3.81 | 5.01 | 6.47 | 6.62 | 6.71 |
| Borrowings | 5.00 | 4.38 | 5.46 | 5.69 | 7.46 | 7.55 | 7.46 | 25.90 | 25.94 | 25.19 | 25.67 | 34.08 | 31.82 |
| Other Liabilities | 3.98 | 10.22 | 6.66 | 6.96 | 6.30 | 5.06 | 6.86 | 14.25 | 17.09 | 16.50 | 23.56 | 18.20 | 19.04 |
| Total Liabilities | 9.97 | 15.46 | 13.13 | 13.86 | 15.22 | 14.54 | 16.31 | 51.57 | 55.36 | 55.22 | 64.22 | 67.42 | 66.09 |
| Fixed Assets | 3.72 | 3.03 | 2.81 | 3.50 | 3.60 | 3.86 | 3.66 | 7.83 | 7.71 | 8.84 | 9.77 | 10.18 | 10.06 |
| CWIP | 0.30 | 0.30 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 5.95 | 12.13 | 10.31 | 10.36 | 11.62 | 10.68 | 12.65 | 43.74 | 47.65 | 46.38 | 54.45 | 57.24 | 56.03 |
| Total Assets | 9.97 | 15.46 | 13.13 | 13.86 | 15.22 | 14.54 | 16.31 | 51.57 | 55.36 | 55.22 | 64.22 | 67.42 | 66.09 |
Below is a detailed analysis of the balance sheet data for Axel Polymers Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 8.52 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 8.52 Cr..
- For Reserves, as of Sep 2025, the value is 6.71 Cr.. The value appears strong and on an upward trend. It has increased from 6.62 Cr. (Mar 2025) to 6.71 Cr., marking an increase of 0.09 Cr..
- For Borrowings, as of Sep 2025, the value is 31.82 Cr.. The value appears to be improving (decreasing). However, Borrowings exceed Reserves, which may signal higher financial risk. It has decreased from 34.08 Cr. (Mar 2025) to 31.82 Cr., marking a decrease of 2.26 Cr..
- For Other Liabilities, as of Sep 2025, the value is 19.04 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 18.20 Cr. (Mar 2025) to 19.04 Cr., marking an increase of 0.84 Cr..
- For Total Liabilities, as of Sep 2025, the value is 66.09 Cr.. The value appears to be improving (decreasing). It has decreased from 67.42 Cr. (Mar 2025) to 66.09 Cr., marking a decrease of 1.33 Cr..
- For Fixed Assets, as of Sep 2025, the value is 10.06 Cr.. The value appears to be declining and may need further review. It has decreased from 10.18 Cr. (Mar 2025) to 10.06 Cr., marking a decrease of 0.12 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 56.03 Cr.. The value appears to be declining and may need further review. It has decreased from 57.24 Cr. (Mar 2025) to 56.03 Cr., marking a decrease of 1.21 Cr..
- For Total Assets, as of Sep 2025, the value is 66.09 Cr.. The value appears to be declining and may need further review. It has decreased from 67.42 Cr. (Mar 2025) to 66.09 Cr., marking a decrease of 1.33 Cr..
However, the Borrowings (31.82 Cr.) are higher than the Reserves (6.71 Cr.), which may signal higher financial risk.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -5.49 | -2.93 | -4.30 | -4.56 | -6.14 | -5.89 | -6.07 | -21.99 | -21.83 | -20.07 | -19.87 | -30.12 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 158.87 | 123.32 | 86.08 | 33.94 | 36.68 | 26.36 | 33.47 | 100.01 | 57.02 | 33.87 | 31.19 | 51.56 |
| Inventory Days | 130.41 | 127.01 | 102.73 | 123.25 | 113.12 | 146.24 | 184.09 | 218.96 | 166.83 | 168.33 | 125.70 | 215.52 |
| Days Payable | 180.68 | 175.90 | 38.81 | 36.63 | 19.49 | 20.20 | 62.21 | 125.81 | 95.43 | 80.23 | 71.47 | 91.43 |
| Cash Conversion Cycle | 108.60 | 74.43 | 150.00 | 120.56 | 130.30 | 152.40 | 155.35 | 193.16 | 128.43 | 121.97 | 85.42 | 175.64 |
| Working Capital Days | -115.54 | 4.51 | 47.27 | 12.48 | 20.71 | 13.33 | 18.33 | 33.16 | 27.78 | 30.74 | 24.77 | 29.87 |
| ROCE % | -12.36% | 17.99% | 16.91% | 17.35% | 13.65% | 14.67% | 11.09% | 16.63% | 11.06% | 12.63% | 12.95% | 7.88% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Diluted EPS (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.44 |
| Cash EPS (Rs.) | 0.86 | 2.65 | 2.02 | 1.64 | 1.30 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 17.77 | 17.60 | 15.89 | 14.47 | 5.11 |
| Revenue From Operations / Share (Rs.) | 91.68 | 150.19 | 100.02 | 85.61 | 53.58 |
| PBDIT / Share (Rs.) | 4.82 | 6.84 | 6.34 | 5.48 | 3.74 |
| PBIT / Share (Rs.) | 4.16 | 6.02 | 5.70 | 4.91 | 2.88 |
| PBT / Share (Rs.) | 0.36 | 2.68 | 2.00 | 1.58 | 0.28 |
| Net Profit / Share (Rs.) | 0.20 | 1.83 | 1.39 | 1.08 | 0.43 |
| PBDIT Margin (%) | 5.25 | 4.55 | 6.33 | 6.39 | 6.97 |
| PBIT Margin (%) | 4.53 | 4.00 | 5.70 | 5.73 | 5.37 |
| PBT Margin (%) | 0.39 | 1.78 | 1.99 | 1.84 | 0.53 |
| Net Profit Margin (%) | 0.22 | 1.21 | 1.39 | 1.25 | 0.81 |
| Return on Networth / Equity (%) | 1.14 | 10.37 | 8.75 | 7.43 | 8.58 |
| Return on Capital Employeed (%) | 16.17 | 22.87 | 23.95 | 23.85 | 16.73 |
| Return On Assets (%) | 0.25 | 2.41 | 2.12 | 1.65 | 0.85 |
| Long Term Debt / Equity (X) | 0.42 | 0.47 | 0.47 | 0.40 | 0.64 |
| Total Debt / Equity (X) | 2.25 | 1.71 | 1.86 | 2.10 | 3.99 |
| Asset Turnover Ratio (%) | 1.18 | 2.13 | 1.54 | 1.88 | 1.20 |
| Current Ratio (X) | 1.19 | 1.23 | 1.23 | 1.17 | 1.17 |
| Quick Ratio (X) | 0.32 | 0.28 | 0.30 | 0.42 | 0.40 |
| Inventory Turnover Ratio (X) | 1.98 | 3.54 | 2.37 | 3.08 | 1.82 |
| Interest Coverage Ratio (X) | 1.27 | 2.05 | 1.71 | 1.64 | 1.44 |
| Interest Coverage Ratio (Post Tax) (X) | 1.05 | 1.55 | 1.38 | 1.32 | 1.17 |
| Enterprise Value (Cr.) | 66.75 | 85.41 | 60.02 | 67.20 | 14.08 |
| EV / Net Operating Revenue (X) | 0.85 | 0.66 | 0.70 | 0.92 | 0.61 |
| EV / EBITDA (X) | 16.27 | 14.65 | 11.12 | 14.41 | 8.76 |
| MarketCap / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| Price / BV (X) | 2.30 | 4.05 | 2.65 | 3.42 | 2.43 |
| Price / Net Operating Revenue (X) | 0.44 | 0.47 | 0.42 | 0.57 | 0.23 |
| EarningsYield | 0.00 | 0.02 | 0.03 | 0.02 | 0.03 |
After reviewing the key financial ratios for Axel Polymers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Diluted EPS (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 5. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For Cash EPS (Rs.), as of Mar 25, the value is 0.86. This value is below the healthy minimum of 3. It has decreased from 2.65 (Mar 24) to 0.86, marking a decrease of 1.79.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 17.77. It has increased from 17.60 (Mar 24) to 17.77, marking an increase of 0.17.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 91.68. It has decreased from 150.19 (Mar 24) to 91.68, marking a decrease of 58.51.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 4.82. This value is within the healthy range. It has decreased from 6.84 (Mar 24) to 4.82, marking a decrease of 2.02.
- For PBIT / Share (Rs.), as of Mar 25, the value is 4.16. This value is within the healthy range. It has decreased from 6.02 (Mar 24) to 4.16, marking a decrease of 1.86.
- For PBT / Share (Rs.), as of Mar 25, the value is 0.36. This value is within the healthy range. It has decreased from 2.68 (Mar 24) to 0.36, marking a decrease of 2.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 0.20. This value is below the healthy minimum of 2. It has decreased from 1.83 (Mar 24) to 0.20, marking a decrease of 1.63.
- For PBDIT Margin (%), as of Mar 25, the value is 5.25. This value is below the healthy minimum of 10. It has increased from 4.55 (Mar 24) to 5.25, marking an increase of 0.70.
- For PBIT Margin (%), as of Mar 25, the value is 4.53. This value is below the healthy minimum of 10. It has increased from 4.00 (Mar 24) to 4.53, marking an increase of 0.53.
- For PBT Margin (%), as of Mar 25, the value is 0.39. This value is below the healthy minimum of 10. It has decreased from 1.78 (Mar 24) to 0.39, marking a decrease of 1.39.
- For Net Profit Margin (%), as of Mar 25, the value is 0.22. This value is below the healthy minimum of 5. It has decreased from 1.21 (Mar 24) to 0.22, marking a decrease of 0.99.
- For Return on Networth / Equity (%), as of Mar 25, the value is 1.14. This value is below the healthy minimum of 15. It has decreased from 10.37 (Mar 24) to 1.14, marking a decrease of 9.23.
- For Return on Capital Employeed (%), as of Mar 25, the value is 16.17. This value is within the healthy range. It has decreased from 22.87 (Mar 24) to 16.17, marking a decrease of 6.70.
- For Return On Assets (%), as of Mar 25, the value is 0.25. This value is below the healthy minimum of 5. It has decreased from 2.41 (Mar 24) to 0.25, marking a decrease of 2.16.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.42. This value is within the healthy range. It has decreased from 0.47 (Mar 24) to 0.42, marking a decrease of 0.05.
- For Total Debt / Equity (X), as of Mar 25, the value is 2.25. This value exceeds the healthy maximum of 1. It has increased from 1.71 (Mar 24) to 2.25, marking an increase of 0.54.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.18. It has decreased from 2.13 (Mar 24) to 1.18, marking a decrease of 0.95.
- For Current Ratio (X), as of Mar 25, the value is 1.19. This value is below the healthy minimum of 1.5. It has decreased from 1.23 (Mar 24) to 1.19, marking a decrease of 0.04.
- For Quick Ratio (X), as of Mar 25, the value is 0.32. This value is below the healthy minimum of 1. It has increased from 0.28 (Mar 24) to 0.32, marking an increase of 0.04.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 1.98. This value is below the healthy minimum of 4. It has decreased from 3.54 (Mar 24) to 1.98, marking a decrease of 1.56.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 1.27. This value is below the healthy minimum of 3. It has decreased from 2.05 (Mar 24) to 1.27, marking a decrease of 0.78.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 1.05. This value is below the healthy minimum of 3. It has decreased from 1.55 (Mar 24) to 1.05, marking a decrease of 0.50.
- For Enterprise Value (Cr.), as of Mar 25, the value is 66.75. It has decreased from 85.41 (Mar 24) to 66.75, marking a decrease of 18.66.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.85. This value is below the healthy minimum of 1. It has increased from 0.66 (Mar 24) to 0.85, marking an increase of 0.19.
- For EV / EBITDA (X), as of Mar 25, the value is 16.27. This value exceeds the healthy maximum of 15. It has increased from 14.65 (Mar 24) to 16.27, marking an increase of 1.62.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For Price / BV (X), as of Mar 25, the value is 2.30. This value is within the healthy range. It has decreased from 4.05 (Mar 24) to 2.30, marking a decrease of 1.75.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.47 (Mar 24) to 0.44, marking a decrease of 0.03.
- For EarningsYield, as of Mar 25, the value is 0.00. This value is below the healthy minimum of 5. It has decreased from 0.02 (Mar 24) to 0.00, marking a decrease of 0.02.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Axel Polymers Ltd:
- Net Profit Margin: 0.22%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 16.17% (Industry Average ROCE: 16.3%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 1.14% (Industry Average ROE: 12.17%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 1.05
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.32
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 29.8 (Industry average Stock P/E: 46.22)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 2.25
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 0.22%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Plastic & Plastic Products | S.No.309, VIL Mokshi, Sankarda-Savli Road, Vadodra District Gujarat 391780 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Gaurav Thanky | Chairman & Managing Director |
| Mrs. Dhara Gaurav Thanky | Non Executive Woman Director |
| Mr. Chirag Shah | Addnl.Non Exe.Independent Director |
| Mr. Ashok Shah | Addnl.Non Exe.Independent Director |
FAQ
What is the intrinsic value of Axel Polymers Ltd?
Axel Polymers Ltd's intrinsic value (as of 14 February 2026) is ₹4.19 which is 90.67% lower the current market price of ₹44.90, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹49.4 Cr. market cap, FY2025-2026 high/low of ₹60.0/27.7, reserves of ₹6.71 Cr, and liabilities of ₹66.09 Cr.
What is the Market Cap of Axel Polymers Ltd?
The Market Cap of Axel Polymers Ltd is 49.4 Cr..
What is the current Stock Price of Axel Polymers Ltd as on 14 February 2026?
The current stock price of Axel Polymers Ltd as on 14 February 2026 is ₹44.9.
What is the High / Low of Axel Polymers Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Axel Polymers Ltd stocks is ₹60.0/27.7.
What is the Stock P/E of Axel Polymers Ltd?
The Stock P/E of Axel Polymers Ltd is 29.8.
What is the Book Value of Axel Polymers Ltd?
The Book Value of Axel Polymers Ltd is 13.8.
What is the Dividend Yield of Axel Polymers Ltd?
The Dividend Yield of Axel Polymers Ltd is 0.00 %.
What is the ROCE of Axel Polymers Ltd?
The ROCE of Axel Polymers Ltd is 7.88 %.
What is the ROE of Axel Polymers Ltd?
The ROE of Axel Polymers Ltd is 1.13 %.
What is the Face Value of Axel Polymers Ltd?
The Face Value of Axel Polymers Ltd is 10.0.